Oncolytics Biotech Stock Market Value
| ONCY Stock | USD 0.93 0.02 2.11% |
| Symbol | Oncolytics |
Oncolytics Biotech Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncolytics Biotech. If investors know Oncolytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncolytics Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Return On Assets (0.71) | Return On Equity (1.38) |
The market value of Oncolytics Biotech is measured differently than its book value, which is the value of Oncolytics that is recorded on the company's balance sheet. Investors also form their own opinion of Oncolytics Biotech's value that differs from its market value or its book value, called intrinsic value, which is Oncolytics Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncolytics Biotech's market value can be influenced by many factors that don't directly affect Oncolytics Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncolytics Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncolytics Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncolytics Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oncolytics Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncolytics Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncolytics Biotech.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Oncolytics Biotech on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Oncolytics Biotech or generate 0.0% return on investment in Oncolytics Biotech over 30 days. Oncolytics Biotech is related to or competes with Ikena Oncology, Eliem Therapeutics, HCW Biologics, RenovoRx, Tempest Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals. Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of phar... More
Oncolytics Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncolytics Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oncolytics Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.89 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 36.56 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 7.83 |
Oncolytics Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncolytics Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncolytics Biotech's standard deviation. In reality, there are many statistical measures that can use Oncolytics Biotech historical prices to predict the future Oncolytics Biotech's volatility.| Risk Adjusted Performance | 0.0188 | |||
| Jensen Alpha | 0.1365 | |||
| Total Risk Alpha | (0.76) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.1) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oncolytics Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oncolytics Biotech Backtested Returns
At this stage we consider Oncolytics Stock to be very risky. Oncolytics Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0164, which implies the firm had a 0.0164% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Oncolytics Biotech, which you can use to evaluate the volatility of the company. Please check Oncolytics Biotech's Risk Adjusted Performance of 0.0188, semi deviation of 3.53, and Coefficient Of Variation of 7489.51 to confirm if the risk estimate we provide is consistent with the expected return of 0.0913%. Oncolytics Biotech has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of -0.64, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Oncolytics Biotech are expected to decrease at a much lower rate. During the bear market, Oncolytics Biotech is likely to outperform the market. Oncolytics Biotech right now holds a risk of 5.56%. Please check Oncolytics Biotech total risk alpha and the relationship between the downside variance and period momentum indicator , to decide if Oncolytics Biotech will be following its historical price patterns.
Auto-correlation | 0.76 |
Good predictability
Oncolytics Biotech has good predictability. Overlapping area represents the amount of predictability between Oncolytics Biotech time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oncolytics Biotech price movement. The serial correlation of 0.76 indicates that around 76.0% of current Oncolytics Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Oncolytics Biotech lagged returns against current returns
Autocorrelation, which is Oncolytics Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oncolytics Biotech's stock expected returns. We can calculate the autocorrelation of Oncolytics Biotech returns to help us make a trade decision. For example, suppose you find that Oncolytics Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oncolytics Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oncolytics Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oncolytics Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oncolytics Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Oncolytics Biotech Lagged Returns
When evaluating Oncolytics Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oncolytics Biotech stock have on its future price. Oncolytics Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oncolytics Biotech autocorrelation shows the relationship between Oncolytics Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Oncolytics Biotech.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.